At Baysient, it is our mission to help patients achieve remission from their inflammatory diseases. The traditional dosing process for such conditions leads to expensive medical costs overall and makes long-term remission challenging to achieve and maintain. Through precision and customized dosing, Baysient’s iDose software can help lower medical costs while reducing the incidence of anti-drug antibodies, leading to long-term remission. 

Infliximab (IFX) is the most widely prescribed medication for patients with inflammatory bowel disease (IBD) and other inflammatory diseases. While this medication is highly effective in inducing remission in patients, a large proportion of patients will either not achieve remission or will lose response to IFX, often due to the development of anti-drug antibodies. Baysient’s iDose system determines doses and dose intervals designed to maintain the physician-selected target trough for each patient to help them achieve excellent medical outcomes. 

Baysient has conducted prospective clinical trials that confirm superior outcomes in patients dosed using iDose. Our studies confirmed patients achieved and sustained remission significantly more than with standard of care, and that there was a reduced incidence of anti-drug antibodies. Precision dosing considers the various factors that impact the way a patient’s body clears medication (half-life), analyzing and forecasting optimal dosing regimens to maintain a physician targeted trough. 

The cloud-based iDose software offers medical providers a complete guide to precision dosing. Within milliseconds of entering patient information, physicians get several precise, model-informed doses for their patients, allowing the physician and patient to work together to determine the most suitable regimen to use. This approach requires few or no therapeutic drug monitoring, and may help prevent medication switches. iDose allows physicians to select the appropriate dose of Infliximab to maintain therapeutic trough levels during induction and maintenance, helping them achieve and maintain remission. 

Get started with iDose today and begin improving your patient outcomes. Schedule your demo with us today!